A comprehensive view of u.s. food and drug administration (fda). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

FDA's top food safety official Frank Yiannas resigns, citing concerns about the agency's oversight structure and the infant formula crisis that led to a nationwide shortage; resignation official Feb. 24
Published: January 25, 2023 by Associated Press
Natura PCR announces FDA Letter of Non-Objection, certifying the company's 100% recycled LLDPE is suitable for direct food contact packaging applications
Published: January 25, 2023 by PR Newswire
AGC Biologics tapped to produce long-awaited diabetes drug
Published: January 25, 2023 by FiercePharma
FDA releases guidance for outsourcing facilities compounding certain ibuprofen oral suspension products; guidance intended to help hospitals, health systems meet demand for fever-reducing products during respiratory illness surge
Published: January 25, 2023 by The American Hospital Association (AHA)
US FDA releases federal guidance on clinical drug trials for cannabis in humans; guidance also includes methods to calculate THC differences between hemp and marijuana
Published: January 24, 2023 by Green Market Report

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count